Product Images Esbriet

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Esbriet NDC 83107-029 by Legacy Pharma Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - esbriet 01

Chemical Structure - esbriet 01

Figure 1 - esbriet 02

Figure 1 - esbriet 02

This description provides numeric data related to the change in %FVC (Forced Vital Capacity) over time for two groups: the ESBRIET group (n=278) and the Placebo group (n=277). The data includes percentages such as 100%, 80%, 70%, and other varying values from -10 to 30%, representing the changes in %FVC from baseline to week 52 for the groups. The chart shows the absolute change in %FVC for both groups, indicating whether there was a worsening or no decline over the specified time period.*

Figure 2 - esbriet 03

Figure 2 - esbriet 03

Figure 3 - esbriet 04

Figure 3 - esbriet 04

This is a clinical trial report showing the percentage of patients alive over time for patients taking Esbriet (pirfenidone) compared to a placebo. The hazard ratio (HR) with a 95% confidence interval is reported as 0.75 (0.51-1.11). The number of patients at risk over weeks is also provided.*

image description - esbriet 06a

image description - esbriet 06a

image description - esbriet 07a

image description - esbriet 07a

This text provides information about a medication known as Esbriet (pirfenidone), consisting of 90 tablets. The dosage details are not available in the text.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.